Legacy Education LGCY Stock Steady at 1223 Support at 1162 20260514 Trump Halts Planned Iran Strike After Gulf State Intervention Citing Ongoing Negotiations Castle Bio CSTL Gained 099 Can It Break 2029 20260518 ESG Momentum Shifts Why Moral Leadership Endures in Corporate Strategy Nuveen NMI Stock Analysis Climbs 065 Eyes on 1131 20260520 How Low Will Ondas ONDS Go After 069 SellOff 20260521 Dyadic DYAI Surges 055 Nearing 076 Resistance 20260520 Why NeuroSense Therapeutics NRSN Just Surged 906 Key Levels Ahead 20260520 Alibaba Unveils Upgraded Zhenwu AI Chip and New Large Language Model Princeton CorpGov Forum Explores Value Creation Plans in Private Equity Governance EasyJet FirstHalf Losses Widen as Iran Conflict Drives Fuel Costs Higher and Dents Summer Bookings Wall Street Gains Amid Iran Peace Talks Estee Lauder and Zoom Lead Advancers Bitcoin Dips Below 77000 on Gate Exchange as Rally Shows Signs of Cooling OpenAI Reportedly Plans Confidential IPO Filing Aiming to Lead AI Race Unity Software Q1 2026 Earnings EPS Beat Surprises Despite Revenue Disappointment Hawaiian Electric Industries Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Brighthouse Financial Inc BHFAM Q1 2026 Earnings EPS Misses Estimates but Stock Edges Higher KW Q1 2026 Earnings Strong EPS Surprise Amidst Challenging Market PPG Q1 2026 Earnings EPS Surpasses Estimates Amidst Stable Demand Trump Postpones AI Executive Order Citing Concerns Over Potential Constraints BitGo Holdings Inc BTGO Q1 2026 Earnings Deep EPS Miss Sends Shares Down 107 Hilltop Holdings Inc Q1 2026 Earnings EPS Beat Surprises Analysts by 30 REZI Q1 2026 Earnings EPS Beats Estimates Stock Gains 4 Goldman Sachs BDC Inc GSBD Q1 2026 Earnings EPS Miss Weighs on Shares Despite Steady Portfolio Performance bioAffinity Technologies BIAF Q3 2025 Earnings Significant EPS Miss as Revenue Remains Zero Stock Declines 37 FWONA Q4 2025 Earnings Modest EPS Miss Amid Steady Operational Progress Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development WIT Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gain